115 related articles for article (PubMed ID: 7658730)
1. Disseminated nasal T cell lymphoma with a partial deletion of the LMP1 oncogene in a patient with chronic active Epstein-Barr virus infection.
Minegishi M; Ohashi Y; Tsuchiya S; Fujie H; Ichinohasama R; Nakagawa H; Konno T
Leukemia; 1995 Sep; 9(9):1595-8. PubMed ID: 7658730
[No Abstract] [Full Text] [Related]
2. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
3. Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas.
van Gorp J; Brink A; Oudejans JJ; van den Brule AJ; van den Tweel JG; Jiwa NM; de Bruin PC; Meijer CJ
J Clin Pathol; 1996 Jan; 49(1):72-6. PubMed ID: 8666691
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.
Kanavaros P; Briere J; Emile JF; Gaulard P
Leukemia; 1996 Jun; 10 Suppl 2():s84-7. PubMed ID: 8649060
[TBL] [Abstract][Full Text] [Related]
5. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
Zhao S; Liu WP; Zhang WY; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and human T-cell lymphomas.
Meijer CJ; Jiwa NM; Dukers DF; Oudejans JJ; de Bruin PC; Walboomers JM; van den Brule AJ
Semin Cancer Biol; 1996 Aug; 7(4):191-6. PubMed ID: 8946603
[TBL] [Abstract][Full Text] [Related]
7. Nasal natural killer/T cell lymphoma: case report with molecular biologic examination on Epstein-Barr virus and cell cycle regulatory p16, cyclin D1, Rb, and p53 genes.
Baba Y; Tsukuda M; Kagata H; Kato Y; Nakatani Y; Ehara M; Nagashima Y; Taki A; Aoki I
J Otolaryngol; 2000 Apr; 29(2):121-5. PubMed ID: 10819114
[No Abstract] [Full Text] [Related]
8. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus.
Le Goff P; Chicault P; Saraux A; Baron D; Valls-Bellec I; Leroy JP
Rev Rhum Engl Ed; 1998 Apr; 65(4):283-6. PubMed ID: 9599798
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and nasopharyngeal cancer.
Meisler AI
N Engl J Med; 1996 Jan; 334(2):122; author reply 122-3. PubMed ID: 8531952
[No Abstract] [Full Text] [Related]
12. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan.
Tomita Y; Ohsawa M; Mishiro Y; Kubo T; Maeshiro N; Kojya S; Noda Y; Aozasa K
Lab Invest; 1995 Aug; 73(2):190-6. PubMed ID: 7637319
[TBL] [Abstract][Full Text] [Related]
13. [Epstein-Barr virus infection in midline malignant reticulosis].
Liu W; van Gorp J; Li G
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):49-52. PubMed ID: 10743056
[TBL] [Abstract][Full Text] [Related]
14. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer: a new Epstein-Barr virus-associated disease?
Magrath I; Bhatia K
J Natl Cancer Inst; 1999 Aug; 91(16):1349-50. PubMed ID: 10451431
[No Abstract] [Full Text] [Related]
16. Development of EBV-positive T-cell lymphoma following infection of peripheral blood T cells with EBV.
Kanegane H; Miyawaki T; Yachie A; Oh-Ishi T; Bhatia K; Tosato G
Leuk Lymphoma; 1999 Aug; 34(5-6):603-7. PubMed ID: 10492086
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
18. [Extranodal NK/T-cell lymphoma, nasal type].
Sato Y; Yoshino T
Rinsho Ketsueki; 2007 May; 48(5):353-4. PubMed ID: 17571578
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
20. LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway.
Sun L; Zhao Y; Shi H; Ma C; Wei L
Oncol Rep; 2015 Dec; 34(6):3264-71. PubMed ID: 26397141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
